Table 2 Baseline chemical markers (with cut-offs) of the study population (n=1,096)
Factor | Strata | n | % |
|---|---|---|---|
Bilirubin | Normal | 624 | 56.9% |
High (>1.2 mg/dL) | 31 | 2.8% | |
Unknown | 441 | 40.2% | |
Total Cholesterol | Normal | 478 | 43.6% |
High (≥200 mg/dL) | 107 | 9.8% | |
Unknown | 511 | 46.6% | |
Hemoglobin | Low (<12 g/dL) | 158 | 14.4% |
Normal | 593 | 54.1% | |
Unknown | 345 | 31.5% | |
GammaGT | Normal | 453 | 41.3% |
High (>60 IU/L) | 145 | 13.2% | |
Unknown | 498 | 45.4% | |
Glucose | Normal | 674 | 61.5% |
High (>110 mg/dl) | 34 | 3.1% | |
Diabetes (>126 mg/dL) | 22 | 2.0% | |
Unknown | 366 | 33.4% | |
GPT | Normal | 561 | 51.2% |
High (>40 IU/L) | 224 | 20.4% | |
Unknown | 311 | 28.4% | |
HDL | Low (<40 mg/dL) | 217 | 19.8% |
Normal | 121 | 11.0% | |
Unknown | 758 | 69.2% | |
LDL | Normal | 306 | 27.9% |
High (≥130 mg/dL) | 12 | 1.1% | |
Unknown | 778 | 71.0% | |
Tryglicerides | Normal | 383 | 34.9% |
high (≥150 mg/dL) | 178 | 16.2% | |
Unknown | 535 | 48.8% | |
MDRD | Low (<60 mg/dL/1.73m2) | 20 | 1.8% |
Normal | 694 | 63.3% | |
Unknown | 382 | 34.9% |